Sunzen Biotech Berhad announced the redesignation of FONG CHAN SENG, aged 76, from Independent and Non Executive Member of Nomination Committee to Independent and Non Executive Chairman of Nomination Committee. Date of Change: March 1, 2023. Composition of Nomination Committee(Name and Directorate of members after change): Chairman: Dr. Fong Chan Seng (Independent Non-Executive Director), Members: Mr. Khoo Kien Hoe (Independent Non-Executive Director), Ms Poo Long Yii (Independent Non-Executive Director).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.355 MYR | +2.90% |
|
-6.58% | +18.33% |
1st Jan change | Capi. | |
---|---|---|
+18.33% | 53.48M | |
-9.08% | 88.33B | |
+0.20% | 40.46B | |
-12.44% | 39.32B | |
+0.29% | 37.81B | |
+0.55% | 36.98B | |
-17.61% | 29.42B | |
-4.37% | 29.35B | |
+4.90% | 23.44B | |
-13.15% | 21.66B |
- Stock Market
- Equities
- SUNZEN Stock
- News Sunzen Biotech
- Sunzen Biotech Berhad Announces Redesignation of FONG CHAN SENG from Independent and Non Executive Member of Nomination Committee to Independent and Non Executive Chairman of Nomination Committee, Effective March 1, 2023